Shares of Bioventix PLC (LON:BVXP – Get Free Report) passed above its 50 day moving average during trading on Tuesday. The stock has a 50 day moving average of GBX 1,630.32 and traded as high as GBX 1,850. Bioventix shares last traded at GBX 1,656.32, with a volume of 15,637 shares changing hands.
Bioventix Trading Up 1.9%
The firm’s fifty day moving average is GBX 1,639.98 and its 200-day moving average is GBX 1,646.69. The stock has a market capitalization of £93.16 million, a P/E ratio of 12.69 and a beta of 0.56.
Bioventix Company Profile
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.
Featured Articles
- Five stocks we like better than Bioventix
- ASML Can’t Keep Up With AI Demand—Why That’s a Good Thing
- Enovix’s 100,000-Battery Drone Order Sets Up a Test of Its Production Plans
- AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.
